End-of-day quote
Other stock markets
|
5-day change | 1st Jan Change | ||
7.03 EGP | +0.43% | -4.22% | -48.12% |
Strengths
- The company's EBITDA/Sales ratio is relatively high and results in high margins before depreciation, amortization and taxes.
- The group's high margin levels account for strong profits.
- The company's share price in relation to its net book value makes it look relatively cheap.
- The company has a low valuation given the cash flows generated by its activity.
- Over the last twelve months, the sales forecast has been frequently revised upwards.
- The average target price set by analysts covering the stock is above current prices and offers a tremendous appreciation potential.
Weaknesses
- The price targets of various analysts who make up the consensus differ significantly. This reflects different assessments and/or a difficulty in valuing the company.
Ratings chart - Surperformance
Sector: Diversified Chemicals
1st Jan change | Capi. | Investor Rating | ESG Refinitiv | |
---|---|---|---|---|
-48.12% | 174M | - | - | |
+1.22% | 77.72B | B | ||
+0.66% | 32.51B | C | ||
+8.75% | 18.21B | B | ||
-9.28% | 11.6B | B | ||
+8.29% | 11.28B | A- | ||
-2.33% | 9.94B | - | ||
+5.97% | 9.92B | A- | ||
+3.48% | 9.48B | C- | ||
+4.24% | 8.33B | B |
Financials
Valuation
Momentum
Consensus
Business Predictability
Technical analysis
- Stock Market
- Equities
- EGCH Stock
- Ratings Egyptian Chemical Industries